Streptococcal Disease, Invasive Group B

West Virginia Bureau for Public Health gives you an explanation for how to distinguish the Descriptive and Analytic Epidemiology.

Descriptive studies

The descriptive epidemiological study aims to describe the health status of a population by quantifying the importance of health problems. Its objective is to measure, in a population over a period, the frequency of a pathology, the number of new cases of this pathology or the number of deaths related to the pathology (it is called mortality). Play the role of a mad scientist and fight the most harmful viruses and bacteria in the most innovative virtual lab by playing themed casino games. The Uptownacesnodeposit website will offer you free test trials on the best-themed slots games, big enough to experiment, and catch those massive jackpot prizes.

Streptococcal Disease, Invasive Group B

Reporting Guidelines

  • Within 1 week to local health department


  • Streptococcus Group B Protocol

Current Case Definition

  • IDEP Case Definition

Required Forms

  • WVEDSS Invasive Bacterial Disease (Streptococcus

Meningococcal Disease, Invasive

Reporting Guidelines:

  • Within 24 hours to local health department


  • West Virginia IDEP Protocol

Current Case Definition:

  • CDC Case Definition

Required Forms:

  • WVEDSS Invasive Bacterial Disease – Neisseria meningitidis Case Report

General Information:

  • Provider Information
  • Public Information
  • WV Office of Laboratory Services Transport Guidelines for Fastidious Organisms
  • MCV4 Vaccine failure and AST Letter

Surveillance Data:

  • West Virginia Meningococcal Disease, Invasive surveillance data from 1997-2006
  • Meningococcal Disease, Invasive, by Age Group 1995-2005
  • Meningococcal Disease, Invasive, by Month of Onset 1995-2005
  • Meningococcal Disease, Invasive, by Year of Onset 1995-2005
  • Meningococcal Disease, Invasive, by Serogroup and Year of Onset 2000-05

Other Links:

  • National Foundation for Infectious Disease
  • Guillain-Barre Syndrome Among Adolescents Who Received Meningococcal Conjugate Vaccine, Fact Sheet for Healthcare Professionals
  • Guillain-Barre Syndrome Among Recipients of Menactra Meningococcal Congugate Vaccine – United States, June–July 2005
  • FDA and CDC Issue Alert on Menactra Meningococcal Vaccine and Guillain Barré Syndrome
  • CDC Information: Meningococcal Disease, Invasive
  • Prevention and Control of Meningococcal Disease – Recommendations of